mktcap_usd=122702
ConsensRecom=2.67
earning_yield=5.51%
growth=2.25%
dilution=-5.54%
div_ratio=38.86%
sh_payout_ratio=100.00%
margin=26.76%
cfmargin=38.38%
ratiopaid=1.23
sratiopaid=55.91%
ratioConsens=1.12
Description
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-14 | 2018-02-13 | 2019-02-13 | 2020-02-12 | 2021-02-09 | 2022-02-16 | 2023-02-09 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 22991 | 22849 | 23747 | 23362 | 25424 | 25979 | 26323 | 24382 | 1479 |
| revgrowth | NaN | -0.62% | 3.85% | -1.63% | 8.46% | 2.16% | 1.32% | 2.26% | 3.61% |
| earn | 7722 | 1979 | 8394 | 7842 | 7264 | 5893 | 6552 | 6521 | 2171 |
| earnx | 7722 | 8079 | 8394 | 7842 | 7264 | 5893 | 6552 | 7392 | 890 |
| margin | 33.59% | 8.66% | 35.35% | 33.57% | 28.57% | 22.68% | 24.89% | 26.76% | 9.29% |
| xmargin | 33.59% | 35.36% | 35.35% | 33.57% | 28.57% | 22.68% | 24.89% | 30.57% | 5.20% |
| earningyld | 6.86% | 1.52% | 6.57% | 5.41% | 5.43% | 4.63% | 4.76% | 5.03% | 1.76% |
| cfop | 10354 | 11177 | 11296 | 9150 | 10497 | 9261 | 9721 | 10208 | 864 |
| cfinv | -8658 | -4024 | 14339 | 5709 | -5401 | 733 | -6044 | -478 | 8103 |
| cffin | -2599 | -6594 | -22490 | -15767 | -4867 | -8271 | -4037 | -9232 | 7262 |
| cfopmargin | 45.04% | 48.92% | 47.57% | 39.17% | 41.29% | 35.65% | 36.93% | 42.08% | 5.21% |
| cfinvmargin | -37.66% | -17.61% | 60.38% | 24.44% | -21.24% | 2.82% | -22.96% | -1.69% | 34.00% |
| cffinmargin | -11.30% | -28.86% | -94.71% | -67.49% | -19.14% | -31.84% | -15.34% | -38.38% | 31.06% |
| shares | 744 | 725 | 656 | 601 | 582 | 566 | 534 | 630 | 81.0 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | 151 | 180 | 195 | 241 | 230 | 225 | 258 | 211 | 37.5 |
| dilution | NaN | -2.55% | -10.01% | -8.80% | -3.17% | -2.92% | -5.75% | -5.53% | 3.23% |
| dividend | 2998 | 3365 | 3507 | 3509 | 3755 | 4013 | 4196 | 3620 | 404 |
| sharebb | NaN | 3105 | 12942 | 12042 | 4416 | 3816 | 7620 | 7324 | 4300 |
| ltdebtbb | NaN | -3997 | 4680 | 2560 | -5945 | -327 | -4132 | -1194 | 4205 |
| mgtbb | NaN | -4121 | -1361 | 2344 | -2641 | -769 | 3647 | -483 | 2959 |
| divyld | 2.66% | 2.58% | 2.74% | 2.42% | 2.80% | 3.15% | 3.05% | 2.77% | 0.26% |
| sharebbyld | NaN | 2.55% | 10.01% | 8.80% | 3.17% | 2.92% | 5.75% | 5.53% | 3.23% |
| mgtyld | NaN | -3.16% | -1.06% | 1.62% | -1.97% | -0.60% | 2.65% | -0.42% | 2.19% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-02-14 | 2018-02-13 | 2019-02-13 | 2020-02-12 | 2021-02-09 | 2022-02-16 | 2023-02-09 | NaN | NaN |
| mktcap | 112534 | 130564 | 127775 | 144906 | 133892 | 127234 | 137510 | 130631 | 10074 |
| mktcapgrowth | NaN | 14.86% | -2.16% | 12.58% | -7.91% | -5.10% | 7.77% | 3.34% | 9.65% |
| totAsset | 77626 | 79954 | 66416 | 59707 | 62948 | 61165 | 65121 | 67562 | 8021 |
| assetgrowth | NaN | 2.95% | -18.55% | -10.65% | 5.29% | -2.87% | 6.27% | -2.93% | 9.90% |
| curAsset | 46010 | 49476 | 37618 | 18440 | 21144 | 19385 | 22186 | 30608 | 13397 |
| curAssetPct | 59.27% | 61.88% | 56.64% | 30.88% | 33.59% | 31.69% | 34.07% | 44.00% | 14.39% |
| totLiab | 47751 | 54713 | 53916 | 50034 | 53539 | 54465 | 61460 | 53697 | 4296 |
| totLiabPct | 61.51% | 68.43% | 81.18% | 83.80% | 85.05% | 89.05% | 94.38% | 80.49% | 11.57% |
| curLiab | 11204 | 9020 | 13488 | 12835 | 11653 | 12184 | 15687 | 12296 | 2064 |
| curLiabPct | 14.43% | 11.28% | 20.31% | 21.50% | 18.51% | 19.92% | 24.09% | 18.58% | 4.36% |
| ltDebt | 30193 | 34190 | 29510 | 26950 | 32895 | 33222 | 37354 | 32045 | 3433 |
| ltDebtPct | 38.90% | 42.76% | 44.43% | 45.14% | 52.26% | 54.32% | 57.36% | 47.88% | 6.79% |
| Equity | 29875 | 25241 | 12500 | 9673 | 9409 | 6700 | 3661 | 13866 | 9836 |
| EquityPct | 38.49% | 31.57% | 18.82% | 16.20% | 14.95% | 10.95% | 5.62% | 19.51% | 11.57% |
| PB | 3.77 | 5.17 | 10.2 | 15.0 | 14.2 | 19.0 | 37.6 | 15.0 | 11.3 |
Beta
len=92.0
mean=4.97%
sd=22.02%
alpha=0.34%
beta=60.51%
r_sq=23.64%
lastdate=2023-03-17
firstdate=2016-05-31
logret1y=-5.10%
Financial Snapshot
CompanyName=Amgen, Inc.
ID=1
Name=Ordinary Shares
Ticker=AMGN
ISIN=None
RIC=AMGN.O
DisplayRIC=AMGN.OQ
InstrumentPI=260033
QuotePI=7656285
InstrumentPermID=8590930977
QuotePermID=55835313783
Exchange=NASDAQ
ExchangeCode=NASD
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-03-11
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=25200
SharesOut=533976238
TotalFloat=532474452
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=230
NHIG=297
NLOW=223
PDATE=2023-03-17
VOL10DAVG=3.08
EV=152342
MKTCAP=122702
AREV=26323
AEBITD=13548
ANIAC=6552
AEPSXCLXOR=12.1
AREVPS=48.7
ABVPS=6.86
ACSHPS=17.4
ACFSHR=18.4
ADIVSHR=7.76
AGROSMGN=75.7
AROEPCT=126
APR2REV=4.66
APEEXCLXOR=19.0
APRICE2BK=33.5
ConsRecom=2.67
TargetPrice=258
ProjLTGrowthRate=4.12
ProjPE=12.9
ProjSales=26744
ProjSalesQ=6255
ProjEPS=17.8
ProjEPSQ=4.00
ProjProfit=9581
ProjDPS=8.45
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None
Valuation
ticker=AMGN
exchg=AMEX
RIC=AMGN.O
CompanyName=Amgen, Inc.
ExchangeCode=NASD
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=122702
float_usd=122357
ConsensRecom=2.67
earning_yield=5.51%
growth=2.25%
dilution=-5.54%
margin=26.76%
searning_yield=3.74%
sgrowth=-1.04%
smargin=18.16%
sdilution=-2.59%
projearning_yield=7.45%
earning_excl_yield=5.14%
div_ratio=38.86%
bb_ratio=97.69%
sh_payout_ratio=100.00%
PS=4.72
price=230
ratio=1.23
sratio=55.91%
sratiopaid=55.91%
ratioConsens=1.12
turnover=36.62%
cfmargin=38.38%
rdmargin=16.80%
scfmargin=9.63%
quoteccy=USD
quotefx=100.00%
ratiopaid=1.23
dt=2023-03-17
assetgrowth=-2.93%
dlnfx=0